雙塔食品(002481.SZ)擬斥50萬美元在美國設立全資子公司
格隆匯1月7日丨雙塔食品(002481.SZ)公佈,公司因業務經營及發展需要,擬以自有資金50萬美元在美國設立全資子公司:FOLLOW NATURE INC.(暫定名稱,具體以相關部門核定為準)。
FOLLOW NATURE INC.經營範圍:蛋白及蛋白製品、澱粉及澱粉製品、纖維及纖維製品、功能性配料的批發零售。(具體以相關部門核定為準)
在美國設立子公司,有利於擴大公司品牌的國際影響力,提升企業形象;有利於公司進一步拓展海外市嘗優化經營結構、擴大銷量、增加收益,進一步調整公司產業發展佈局,實現收益多元化,提高市場競爭力,加快公司的國際化進程。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.